Form 4: Outset Medical Director James F. Hinrichs Acquires 25,000 Shares of Common Stock
SEC Form 4
Director James F. Hinrichs reports acquisition of 25,000 shares of Outset Medical, Inc. common stock on May 29, 2024.
Summary
- On May 29, 2024, James F. Hinrichs, a director of Outset Medical, Inc., acquired 25,000 shares of common stock.
- The shares were acquired at a price of $0.0.
- Following the transaction, Hinrichs directly owns 80,349 shares of Outset Medical, Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director. While insider buying can be seen as positive, this is a routine filing.
Positives
- A director's acquisition of shares can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders.
Stakeholder Impact
- The acquisition of shares by a director could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of transaction: Acquisition of 25,000 shares of common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.